Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Burden”

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07715396
What this trial is testing

Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden

Who this might be right for
Non-small Cell Lung Cancer Metastatic
AIO-Studien-gGmbH 230
Not applicableStudy completedNCT00839696
What this trial is testing

Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

Who this might be right for
Breast Cancer Risk
University of Wisconsin, Madison 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT05197322
What this trial is testing

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Who this might be right for
Adenocarcinoma of the Colon
University College, London 88
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Large-scale testing (Phase 3)Study completedNCT02809053
What this trial is testing

A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients With Low Tumor Burden Follicular Lymphoma

Who this might be right for
Lymphoma, Follicular
Archigen Biotech Limited 315
Not applicableStudy completedNCT05831293
What this trial is testing

Mindfulness-Based Reduction Stress Program

Who this might be right for
CancerCaregiver StressQuality of Life
Ataturk University 104
Not applicableStudy completedNCT00129467
What this trial is testing

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

Who this might be right for
DepressionPalliative CareCancer+1 more
US Department of Veterans Affairs 47
Not applicableActive Not RecruitingNCT02572934
What this trial is testing

Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)

Who this might be right for
Testicular Cancer
University Medical Center Groningen 281
Testing effectiveness (Phase 2)Looking for participantsNCT06108232
What this trial is testing

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Who this might be right for
Follicular LymphomaTumor
M.D. Anderson Cancer Center 83
Not applicableLooking for participantsNCT06769334
What this trial is testing

Preparing for Life and Academics for Young Childhood Cancer Survivors

Who this might be right for
Childhood Cancer
Nationwide Children's Hospital 105
Not applicableNot Yet RecruitingNCT06198387
What this trial is testing

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

Who this might be right for
Oligo-metastatic Prostate Carcinoma
Changhai Hospital 30
Not applicableStudy completedNCT03521531
What this trial is testing

Burden and Medical Care of Sarcoma in Germany

Who this might be right for
Sarcoma
Technische Universität Dresden 1,309
Testing effectiveness (Phase 2)UnknownNCT02689869
What this trial is testing

Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma

Who this might be right for
Indolent Non-Hodgkin Lymphoma
Ludwig-Maximilians - University of Munich 98
Not applicableStudy completedNCT01037751
What this trial is testing

M. D. Anderson Symptom Inventory - Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 158
Testing effectiveness (Phase 2)Ended earlyNCT01889797
What this trial is testing

Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Indolent Non-Hodgkin's Lymphoma
PrECOG, LLC. 32
Testing effectiveness (Phase 2)Ended earlyNCT04155190
What this trial is testing

Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Who this might be right for
Recurrent Basal Cell Carcinoma
Sol-Gel Technologies, Ltd. 50
Not applicableStudy completedNCT03257917
What this trial is testing

Understanding Value in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Alabama at Birmingham 100
Not applicableStudy completedNCT05502302
What this trial is testing

App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Study completedNCT02257853
What this trial is testing

Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

Who this might be right for
Stress, PsychologicalCaregivers
National Institutes of Health Clinical Center (CC) 53
Not applicableUnknownNCT00336609
What this trial is testing

TRIAD Burden of Illness Mucositis Study

Who this might be right for
Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)
TRIAD Burden of Illness 1,600
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation